EDG2 inhibitors (Fundación Ramón Domínguez)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameEDG2 inhibitors (Fundación Ramón Domínguez)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysophosphatidic acid receptor Edg-2 antagonists
TargetsLysophosphatidic acid receptor Edg-2
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFundación Ramón Domínguez
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFundación Ramón Domínguez
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A